Home › Research › Vascular contributions
Aquaporin-4 deficiency induced white matter injury via upregulated complement component 3 in cerebral small vessel disease
Yun Chen, Lingling Jiang, Dongxiao Yao, Dandan Liu, Yuesong Pan, Yilong Wang. Journal of Neuroinflammation, 2026-01-21
Topic: Brain proteins, microglia and lab models
Plain-language summary
We identified four SNPs (rs335929, rs335930, rs335931 and rs455671) were significantly associated with CSVD presence. Among these, rs335929 variant was correlated with reduced AQP4 mRNA expression. Compared with Aqp4+/+ mice, fractional anisotropy values were decreased in the Sham and BCAS groups in Aqp4−/− mice. Under BCAS conditions, Aqp4−/− mice exhibited more severe demyelination and myelin density in the CC. Intraventricular delivery of AAV2/9-Gfap-AQP4M1 and AAV2/9-Gfap-AQP47×cMyc−Kras attenuated BCAS-induced white matter injury and cognitive function, no significant differences were observed between the two AAV treatment groups. RNA sequencing analysis indicated upregulation of inflammatory responses and complement cascades in the CC of Aqp4−/− mice. Complement component 3 (C3) mRNA was notably elevated in astrocytes isolated from Aqp4−/− mice. Treatment with a C3a receptor antagonist in Aqp4−/− mice improved myelin integrity and reduced MBP loss following BCAS. Reduced AQP4 expression was associated with CSVD presence in clinical studies. Experimentally, Aqp4 deficiency has been shown to exacerbate white matter injury, that effect may be mediated by upregulation of C3 mRNA in Aqp4-deficient astrocytes. Targeting C3 activation may represent a promising strategy to mitigate AQP4 loss-induced white matter injury in CSVD.
What this study adds
Evidence grade: Low
In clinical and mouse work, reduced AQP4 expression was associated with cerebral small vessel disease, and Aqp4-deficient mice showed worse white matter injury that appeared mediated by upregulation of complement component 3. Targeting C3 activation is suggested as a possible strategy, but this is early experimental research and not an established treatment.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chen, Y., Jiang, L., Yao, D., Liu, D., Pan, Y., & Wang, Y. (2026). Aquaporin-4 deficiency induced white matter injury via upregulated complement component 3 in cerebral small vessel disease. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-025-03688-w
Vancouver
Chen Y, Jiang L, Yao D, Liu D, Pan Y, Wang Y. Aquaporin-4 deficiency induced white matter injury via upregulated complement component 3 in cerebral small vessel disease. Journal of Neuroinflammation. 2026. doi:10.1186/s12974-025-03688-w. PMID: 41566527.
BibTeX
@article{chen2026-41566527,
author = {Chen, Yun and Jiang, Lingling and Yao, Dongxiao and Liu, Dandan and Pan, Yuesong and Wang, Yilong},
title = {{Aquaporin-4 deficiency induced white matter injury via upregulated complement component 3 in cerebral small vessel disease}},
journal = {Journal of Neuroinflammation},
year = {2026},
doi = {10.1186/s12974-025-03688-w},
pmid = {41566527},
url = {https://doi.org/10.1186/s12974-025-03688-w}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- We identified four SNPs (rs335929, rs335930, rs335931 and rs455671) were significantly associated with CSVD presence.
- Among these, rs335929 variant was correlated with reduced AQP4 mRNA expression.
- Compared with Aqp4+/+ mice, fractional anisotropy values were decreased in the Sham and BCAS groups in Aqp4−/− mice.
- Under BCAS conditions, Aqp4−/− mice exhibited more severe demyelination and myelin density in the CC.
- Intraventricular delivery of AAV2/9-Gfap-AQP4M1 and AAV2/9-Gfap-AQP47×cMyc−Kras attenuated BCAS-induced white matter injury and cognitive function, no significant differences were observed between the two AAV treatment groups.
Why it matters
In clinical and mouse work, reduced AQP4 expression was associated with cerebral small vessel disease, and Aqp4-deficient mice showed worse white matter injury that appeared mediated by upregulation of complement component 3. Targeting C3 activation is suggested as a possible strategy, but this is early experimental research and not an established treatment.
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 34 of the 96 points we could judge it on, which is 35 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Neuroinflammation) |
| Journal's citation record | 2 / 4 | Journal of Neuroinflammation: journal h-index 216 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 3 / 6 | Cited 4.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Yilong Wang holds only 6 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | Capital Medical University: institution h-index 643 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41566527) |
| Free to read | 2 / 2 | Free to read |
| Points | 34 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 34 of the 96 points we could judge it on is 35 out of 100. |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1186/s12974-025-03688-w
- PubMed: 41566527
- Original source →
- Free full text: Journal of Neuroinflammation →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Vascular contributions from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.